Cargando…

Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model

Standardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, Sixten, Hörstedt, Ann-Sofi, Carlsson, Tobias, Nilbert, Mef, Larsson, Anna-Maria, Ohlsson, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636179/
https://www.ncbi.nlm.nih.gov/pubmed/37945664
http://dx.doi.org/10.1038/s41598-023-46757-x
_version_ 1785133158368280576
author Borg, Sixten
Hörstedt, Ann-Sofi
Carlsson, Tobias
Nilbert, Mef
Larsson, Anna-Maria
Ohlsson, Björn
author_facet Borg, Sixten
Hörstedt, Ann-Sofi
Carlsson, Tobias
Nilbert, Mef
Larsson, Anna-Maria
Ohlsson, Björn
author_sort Borg, Sixten
collection PubMed
description Standardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to visualize the patient population going through CPPs, in terms of investigation time and indications of the various outcomes including cancer diagnoses. Our secondary aims were to examine if targets were met, and to examine frequencies of undetected cancer. We collected data from 19,204 patients starting in a CPP, and 7895 patients diagnosed with cancer in 2018 in a region of Sweden. A state transition model was developed and used as analytical framework, and patients were mapped over time in the states of the model. Visualization of the patient-flow through the model illustrates speed of investigation, time to treatment, frequencies of detected and undetected cancer. Twelve CPPs out of 28 met the inclusion target, five met the time target. After suspicion of cancer rejected, 0.8% of patients were diagnosed with the primarily suspected cancer, 1.0% with another cancer. In patients not meeting the criteria for well-founded suspicion less than 3% were later diagnosed with cancer. The visualization of the patient flow into and through standardized cancer patient pathways illustrates investigation time, events occurring and outcomes. The use of standardized cancer patient pathways detects cancer efficiently.
format Online
Article
Text
id pubmed-10636179
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106361792023-11-11 Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model Borg, Sixten Hörstedt, Ann-Sofi Carlsson, Tobias Nilbert, Mef Larsson, Anna-Maria Ohlsson, Björn Sci Rep Article Standardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to visualize the patient population going through CPPs, in terms of investigation time and indications of the various outcomes including cancer diagnoses. Our secondary aims were to examine if targets were met, and to examine frequencies of undetected cancer. We collected data from 19,204 patients starting in a CPP, and 7895 patients diagnosed with cancer in 2018 in a region of Sweden. A state transition model was developed and used as analytical framework, and patients were mapped over time in the states of the model. Visualization of the patient-flow through the model illustrates speed of investigation, time to treatment, frequencies of detected and undetected cancer. Twelve CPPs out of 28 met the inclusion target, five met the time target. After suspicion of cancer rejected, 0.8% of patients were diagnosed with the primarily suspected cancer, 1.0% with another cancer. In patients not meeting the criteria for well-founded suspicion less than 3% were later diagnosed with cancer. The visualization of the patient flow into and through standardized cancer patient pathways illustrates investigation time, events occurring and outcomes. The use of standardized cancer patient pathways detects cancer efficiently. Nature Publishing Group UK 2023-11-09 /pmc/articles/PMC10636179/ /pubmed/37945664 http://dx.doi.org/10.1038/s41598-023-46757-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Borg, Sixten
Hörstedt, Ann-Sofi
Carlsson, Tobias
Nilbert, Mef
Larsson, Anna-Maria
Ohlsson, Björn
Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title_full Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title_fullStr Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title_full_unstemmed Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title_short Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
title_sort performance of standardized cancer patient pathways in sweden visualized using observational data and a state-transition model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636179/
https://www.ncbi.nlm.nih.gov/pubmed/37945664
http://dx.doi.org/10.1038/s41598-023-46757-x
work_keys_str_mv AT borgsixten performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel
AT horstedtannsofi performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel
AT carlssontobias performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel
AT nilbertmef performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel
AT larssonannamaria performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel
AT ohlssonbjorn performanceofstandardizedcancerpatientpathwaysinswedenvisualizedusingobservationaldataandastatetransitionmodel